Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Neuropsychiatry depression

Weller, E.B., Weller, R.A., Fristad, M.A., and Bowes, J.M. (1990) Dexamethasone suppression test and depressive symptoms in bereaved children a preliminary report. / Neuropsychiatry Clin Neurosci 2 418-421. [Pg.123]

Petracca, G., Migliorelli, R., Vazquez, S., and Starkstein, S.E. (1995) SPECT findings before and after ECT in a patient with major depression and Cotard s syndrome. / Neuropsychiatry Clin Neu-rosct 7 505-507. [Pg.135]

Bouckoms Al The role of stereotactic cingulotomy in the treatment of intractable de-pression, in Refractory Depression (Advances in Neuropsychiatry and Psychopharmacology Series, Vol 2. Edited by Amsterdam JD. New York, Raven, 1991, pp 233-242... [Pg.601]

Fink G, Sarkar DK, Dow RC, et al Sex difference in response to alphaxolone may be estrogen dependent. Nature 298 270-272, 1982 Fink M ECT A last resort treatment for resistant depression, in Treating Resistant Depression. Edited by Zohar J, Belmaker RH. Great Neck, NY, PMA, 1987 Fink M A trial of ECT is essential before a diagnosis of refractory depression is made, in Refractory Depression [Advances in Neuropsychiatry and Psychopharmacology, Vol 2). Edited by Amsterdam JD. New York, Raven, 1991, pp 87-92... [Pg.636]

Migliorelli R, Starkstein SE, Teson A, et al SPECT findings in patients with primary mania. J Neuropsychiatry Chn Neurosci 5 379-383, 1993 Miller HE, Delgado PL, Salomon RM, et al Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. Arch Gen Psychiatry 53 117-128, 1996a... [Pg.698]

Nasrallah HA, Varney N, Coffman JA, et al Opiate antagonism fails to reverse post-ECT cognitive deficits. J Clin Psychiatry 47 555-556, 1986 Nasrallah HA, Coffman JA, Olson SC Structural brain-imaging findings in affective disorders an overview. J Neuropsychiatry Clin Neurosci 1 21-26, 1989 Naylor GJ, Smith AHW Defective genetic control of sodium-pump density in manic depressive psychosis. Psychol Med 11 257-263, 1981 Naylor GJ, McNamee HB, Moody JP Erythrocyte sodium and potassium in depressive illness. J Psychosom Res 14 173-177, 1970 Naylor GJ, McNamee HB, Moody JP Changes in erythrocyte sodium and potassium on recovery from depressive illness. Br J Psychiatry 118 219-223, 1971 Naylor GJ, Dick DAT, Dick EG, et al Lithium therapy and erythrocyte membrane cation carrier. Psychopharmacologia 37 81-86, 1974 Naylor GJ, Smith AHW, Dick EG, et al Erythrocyte membrane cation carrier in manic-depressive psychosis. Psychol Med 10 521-525, 1980... [Pg.706]

Fahy P, Imlah N, Harrington J. A controlled comparison of ECT, imipramine and thiopentone sleep in depression. J Neuropsychiatry 1963 4 310-314. [Pg.180]

Figiei G, Epstein C, McDonaid W, et ai. The use of rapid-rate transcraniai magnetic stimuiation (rTMS) in refractory depressed patients. J Neuropsychiatry din Neurosci 1998 10 20-25. [Pg.181]

Sullivan MD. Treatment of depression at the end of life clinical and ethical issues. Semin Clin Neuropsychiatry 1998 3 151-156. [Pg.310]

Fogel, B. S., Stone, A. B. (1992). Practical pathophysiology in neuropsychiatry A clinical approach to depression and impulsive behavior in neurological patients. In S. C. Yu-dofsky R. E. Hales (Eds.), American Psychiatric Press textbook of neuropsychiatry (pp. 329-344). Washington, DC American Psychiatric Press. [Pg.483]

Simonson, M. (1964). Phenothiazine depressive reaction. Journal of Neuropsychiatry, 5, 259-265. [Pg.517]

Scheibel RS, Valentine AD, O Brien S, Meyers CA. Cognitive dysfunction and depression during treatment with interferon-alpha and chemotherapy. J Neuropsychiatry Clin Neurosci 2004 16 185-91. [Pg.709]

Raison CL, Miller AH (2001) The neuroimmunology of stress and depression. Semin Clin Neuropsychiatry 6 277-294. [Pg.493]

Akil M, Schwartz JA, Dutchak D, et al The psychiatric presentations of Wilson s disease. Journal of Neuropsychiatry 3 377-382,1991 Ali SA, Peet M, Ward NI Blood levels of vanadium, caesium, and other elements in depressive patients. J Affect Disord 9 187-191,1985 American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington, DC, American Psychiatric Association, 2000... [Pg.267]

H. Sabelli, Amino Acid Precursors for Depression. Psychiatric Times (October 2000) 42-49 H. C. Sabelli and A. D. Mosnaim, Phenylethylamine Hypothesis of Affective Behavior. American Journal of Psychiatry 131, no. 6 (1974) 695-699 H. C. Sabelli, et al., Sustained Antidepressant Effect of PEA Replacement. Journal of Neuropsychiatry Clinical Neurosciences 8, no. 2 (1996) 168-171 W. Birkmayer, et al., L-Deprenyl Plus L-Phenylalanine in the Treatment of Depression. Journal of Neural Transmission 59, no. 1 (1984) 81-87. H. C. Sabelli, Phenylethylamine Replacement as a Rapid and Physiological Treatment for Depression. Psycheline 2, no. 3 (1998) 32-39. [Pg.273]

An association between cannabis use and neuropsychiatrie conditions is of major importance because of the potential for the use of caimabis as a recreational drug or medicine and also for understanding the biological mechanisms by which catmabinoids act on brain structure and function. In this chapter we review evidence for a number of hypotheses which have been proposed to describe the putative role of caimabis use in the precipitation of psychosis. The majority of studies support the vulnerability hypothesis, especially with respect to schizophrenia. The hypothesis that the consumption of cannabis is a form of self-medication for the symptoms of schizophrenia and depression has also gained support. [Pg.371]

While I have focused primarily on the neuropsychiatry of HE, a number of diverse liver diseases that present with metabolic encephalopathies can be linked to mood dysregulation and depression. This would include illnesses such as hepatolenticular degeneration (Wilson s disease) (Eggers et al., 2003 Hesse et al, 2003 Chan et al., 2005), Gaucher disease (Packman et al., 2006), Fabry disease (Sadek et al., 2004), and hepatitis C infection (Forton et al., 2004). Thus, both the presentation... [Pg.353]

Maser RV, Liao B, Pandya R. Modafinil-induced orofacial dyskinesias in an elderly patient with refractory bipolar depression. J Neuropsychiatry Clin Neurosci 2010 22 4. [Pg.15]

Luborzewski A, Regen F, Schindler F, Anghelescu 1. Modafinil-induced reversible hyperkinetic nondystonic movement disorder in a patient with major depressive disorder. J Neuropsychiatry Clin Neurosci 2006 18 248-9. [Pg.15]

Lai CH. Escitalopram-related visual and auditory hallucination in a non-dementia patient with depression. J Neuropsychiatry CUn Neurosci... [Pg.26]

Li X, Xing B, Yu E, Chen W, Wu H. The combined treatment of venlafaxine and quetiapine for treatment-resistant depression a clinical study. J Neuropsychiatry Clin Neurosci 2013 25(2) 157-60. [Pg.82]

May berg HS (1994) Frontal lobe dysfunction in secondary depression. I Neuropsychiatry Clin Neurosci 6 428-442... [Pg.346]

See other pages where Neuropsychiatry depression is mentioned: [Pg.90]    [Pg.716]    [Pg.180]    [Pg.287]    [Pg.243]    [Pg.411]    [Pg.373]    [Pg.375]    [Pg.377]    [Pg.379]    [Pg.381]    [Pg.581]    [Pg.241]    [Pg.241]   
See also in sourсe #XX -- [ Pg.371 , Pg.372 , Pg.373 , Pg.374 , Pg.375 , Pg.376 , Pg.377 , Pg.378 , Pg.379 , Pg.380 , Pg.381 ]



SEARCH



Neuropsychiatry

© 2024 chempedia.info